Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model.

American journal of neurodegenerative disease Pub Date : 2017-06-15 eCollection Date: 2017-01-01
Paula Garcia-Esparcia, Georgios Sideris-Lampretsas, Karina Hernandez-Ortega, Oriol Grau-Rivera, Theodoros Sklaviadis, Ellen Gelpi, Isidro Ferrer
{"title":"Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model.","authors":"Paula Garcia-Esparcia,&nbsp;Georgios Sideris-Lampretsas,&nbsp;Karina Hernandez-Ortega,&nbsp;Oriol Grau-Rivera,&nbsp;Theodoros Sklaviadis,&nbsp;Ellen Gelpi,&nbsp;Isidro Ferrer","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Expression of the nucleolar chaperones nucleolin (<i>NCL</i>) and nucleophosmin (<i>NPM1</i>), upstream binding transcription factor (<i>UBTF</i>), rRNA18S, rRNA28S, and several genes encoding ribosomal proteins (RPs) is decreased in frontal cortex area 8 at advanced stages of Alzheimer's disease (AD). This is accompanied by reduced protein levels of elongation factors eEF1A and eEF2. Changes are more marked in AD cases with rapid course (rpAD), as initiation factor eIF3η is significantly down-regulated and several RP genes up-regulated in rpAD when compared with typical AD. These changes contrast with those seen in APP/PS1 transgenic mice used as a model of AD-like β-amyloidopathy; <i>Ncl</i> mRNA, rRNA18S, rRNA28S and seven out of fifteen assessed RP genes are up-regulated in APP/PS1 mice aged 20 months; only eEF2 protein levels are reduced in transgenic mice. Our findings show marked altered expression of molecules linked to the protein synthesis machinery from the nucleolus to the ribosome in frontal cortex at terminal stages of AD which differs from that seen in APP/PS1 transgenic mice, thus further suggesting that molecular signals in mouse models do not apply to real human disease counterparts.</p>","PeriodicalId":72170,"journal":{"name":"American journal of neurodegenerative disease","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498849/pdf/ajnd0006-0015.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of neurodegenerative disease","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Expression of the nucleolar chaperones nucleolin (NCL) and nucleophosmin (NPM1), upstream binding transcription factor (UBTF), rRNA18S, rRNA28S, and several genes encoding ribosomal proteins (RPs) is decreased in frontal cortex area 8 at advanced stages of Alzheimer's disease (AD). This is accompanied by reduced protein levels of elongation factors eEF1A and eEF2. Changes are more marked in AD cases with rapid course (rpAD), as initiation factor eIF3η is significantly down-regulated and several RP genes up-regulated in rpAD when compared with typical AD. These changes contrast with those seen in APP/PS1 transgenic mice used as a model of AD-like β-amyloidopathy; Ncl mRNA, rRNA18S, rRNA28S and seven out of fifteen assessed RP genes are up-regulated in APP/PS1 mice aged 20 months; only eEF2 protein levels are reduced in transgenic mice. Our findings show marked altered expression of molecules linked to the protein synthesis machinery from the nucleolus to the ribosome in frontal cortex at terminal stages of AD which differs from that seen in APP/PS1 transgenic mice, thus further suggesting that molecular signals in mouse models do not apply to real human disease counterparts.

Abstract Image

Abstract Image

阿尔茨海默病和小鼠模型中额叶皮层蛋白质合成的改变机制。
在阿尔茨海默病(AD)晚期,前额皮质8区核核伴侣核蛋白(NCL)和核磷脂(NPM1)、上游结合转录因子(UBTF)、rRNA18S、rRNA28S和编码核糖体蛋白(rp)的几个基因的表达减少。这伴随着延伸因子eEF1A和eEF2蛋白水平的降低。与典型AD相比,快速病程AD患者的变化更为明显,因为与典型AD相比,rpAD患者的起始因子eIF3η显著下调,多个RP基因上调。这些变化与作为ad样β-淀粉样病变模型的APP/PS1转基因小鼠的变化形成对比;20月龄APP/PS1小鼠Ncl mRNA、rRNA18S、rRNA28S和15个RP基因中的7个上调;在转基因小鼠中只有eEF2蛋白水平降低。我们的研究结果显示,在阿尔茨海默病晚期,额叶皮层中从核核到核糖体的蛋白质合成机制相关分子的表达明显改变,这与APP/PS1转基因小鼠不同,从而进一步表明小鼠模型中的分子信号并不适用于真正的人类疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信